Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefania Cicalini

Showing results (41-50 of 81) with videos related to

Pageof 9
Sort By:
Methods and Protocols|October 28, 2025
A Six-Step Protocol for Monitoring Antimicrobial Resistance Trends Using WHONET and R: Real-World Application and R Code IntegrationFabio Ingravalle, Antonio Vinci, Marco Ciotti, et al.
AIDS Patient Care and Stds|December 7, 2017
Durability of Second Antiretroviral Regimens in the Italian Cohort Naive Antiretrovirals Foundation Study and Factors Associated with DiscontinuationAntonio Di Biagio, Patrizia Lorenzini, Giulia Gustinetti, et al.
Viruses|August 26, 2022
SARS-CoV-2 Omicron Variant Neutralization after Third Dose Vaccination in PLWHAlessandra Vergori, Alessandro Cozzi-Lepri, Giulia Matusali, et al.
Viruses|August 10, 2021
Impact of HCV Eradication on Lipid Metabolism in HIV/HCV Coinfected Patients: Data from ICONA and HepaICONA Foundation Cohort StudyMartina Spaziante, Gloria Taliani, Giulia Marchetti, et al.
HIV Medicine|January 22, 2021
Virological response and resistance profile in highly treatment-experienced HIV-1-infected patients switching to dolutegravir plus boosted darunavir in clinical practiceDaniele Armenia, Yagai Bouba, Roberta Gagliardini, et al.
Journal of the International AIDS Society|November 14, 2014
Relationship between body mass index and bone mineral density in HIV-infected patients referred for DXACarmela Pinnetti, Lupi Federico, Patrizia Lorenzini, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|January 25, 2023
Results of an interventional HIV testing programme in the context of a mpox (formerly monkeypox) vaccination campaign in Latium Region, Italy, August to October 2022Silvia Pittalis, Valentina Mazzotta, Nicoletta Orchi, et al.
Plos One|October 28, 2017
Peripheral blood HIV-1 DNA dynamics in antiretroviral-treated HIV/HCV co-infected patients receiving directly-acting antiviralsGabriella Rozera, Gabriele Fabbri, Patrizia Lorenzini, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|June 21, 2023
Neutralizing activity and T-cell response after bivalent fifth dose of messenger RNA vaccine in people living with HIVAlessandra Vergori, Giulia Matusali, Alessandro Cozzi Lepri, et al.
Pharmaceuticals (Basel, Switzerland)|January 8, 2025
Effectiveness and Tolerability of DOR/3TC/TDF in Experienced People with HIV Switching from RPV/FTC/TDF: A Retrospective, Single Center Cohort StudyStefania Cicalini, Simone Lanini, Roberta Gagliardini, et al.
Pageof 9

Showing results (41-50 of 81) with videos related to

Sort By:
Pageof 9
Methods and Protocols|October 28, 2025
A Six-Step Protocol for Monitoring Antimicrobial Resistance Trends Using WHONET and R: Real-World Application and R Code IntegrationFabio Ingravalle, Antonio Vinci, Marco Ciotti, et al.
AIDS Patient Care and Stds|December 7, 2017
Durability of Second Antiretroviral Regimens in the Italian Cohort Naive Antiretrovirals Foundation Study and Factors Associated with DiscontinuationAntonio Di Biagio, Patrizia Lorenzini, Giulia Gustinetti, et al.
Viruses|August 26, 2022
SARS-CoV-2 Omicron Variant Neutralization after Third Dose Vaccination in PLWHAlessandra Vergori, Alessandro Cozzi-Lepri, Giulia Matusali, et al.
Viruses|August 10, 2021
Impact of HCV Eradication on Lipid Metabolism in HIV/HCV Coinfected Patients: Data from ICONA and HepaICONA Foundation Cohort StudyMartina Spaziante, Gloria Taliani, Giulia Marchetti, et al.
HIV Medicine|January 22, 2021
Virological response and resistance profile in highly treatment-experienced HIV-1-infected patients switching to dolutegravir plus boosted darunavir in clinical practiceDaniele Armenia, Yagai Bouba, Roberta Gagliardini, et al.
Journal of the International AIDS Society|November 14, 2014
Relationship between body mass index and bone mineral density in HIV-infected patients referred for DXACarmela Pinnetti, Lupi Federico, Patrizia Lorenzini, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|January 25, 2023
Results of an interventional HIV testing programme in the context of a mpox (formerly monkeypox) vaccination campaign in Latium Region, Italy, August to October 2022Silvia Pittalis, Valentina Mazzotta, Nicoletta Orchi, et al.
Plos One|October 28, 2017
Peripheral blood HIV-1 DNA dynamics in antiretroviral-treated HIV/HCV co-infected patients receiving directly-acting antiviralsGabriella Rozera, Gabriele Fabbri, Patrizia Lorenzini, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|June 21, 2023
Neutralizing activity and T-cell response after bivalent fifth dose of messenger RNA vaccine in people living with HIVAlessandra Vergori, Giulia Matusali, Alessandro Cozzi Lepri, et al.
Pharmaceuticals (Basel, Switzerland)|January 8, 2025
Effectiveness and Tolerability of DOR/3TC/TDF in Experienced People with HIV Switching from RPV/FTC/TDF: A Retrospective, Single Center Cohort StudyStefania Cicalini, Simone Lanini, Roberta Gagliardini, et al.
Pageof 9